β-Asarone reduces Beclin-1 and LC3 expression while upregulating p62 in the hippocampi of AD mice (Deng et al., 2020), exhibiting similar effects in vascular dementia models (Ning et al., 2024). Here, MAP1LC3A is linked to Alzheimer disease.